{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2025:DU5C6HLDOX5UFF6756KRSVEP2Q","short_pith_number":"pith:DU5C6HLD","schema_version":"1.0","canonical_sha256":"1d3a2f1d6375fb4297dfef9519548fd409f4bd85263c21d16b9f9d66d974aede","source":{"kind":"arxiv","id":"2509.05825","version":1},"attestation_state":"computed","paper":{"title":"LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Oleksandr Sverdlov, Weng Kee Wong, Yevgen Ryeznik","submitted_at":"2025-09-06T20:40:13Z","abstract_excerpt":"We propose Locally Optimal Restricted Designs (LORDs) for phase I/II dose-finding studies that focus on both efficacy and toxicity outcomes. As an illustrative application, we find various LORDs for a 4-parameter continuation-ratio (CR) model defined on a user-specified dose range, where ethical constraints are imposed to prevent patients from receiving excessively toxic or ineffective doses. We study the structure and efficiency of LORDs across several experimental scenarios and assess the sensitivity of the results to changes in the design problem, such as adjusting the dose range or redefin"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2509.05825","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-09-06T20:40:13Z","cross_cats_sorted":[],"title_canon_sha256":"ef4fc508c3b384b33b93a49e8a817477e5c77b03b8fd98ec7b78cb35952fb6ad","abstract_canon_sha256":"417ef4033e19572b93b43442b1b0601c563730bb0aace260ca9211429ba4e38f"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T12:06:24.849974Z","signature_b64":"rlecY6qzlcK2x4B4Ssp8P3eJ69rD7k/7vPtobnFR9y8MLytkpZ4SS+1lHBjctCuoDU9S17VDtxnIiKYoUjjJBw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"1d3a2f1d6375fb4297dfef9519548fd409f4bd85263c21d16b9f9d66d974aede","last_reissued_at":"2026-07-05T12:06:24.849525Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T12:06:24.849525Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Oleksandr Sverdlov, Weng Kee Wong, Yevgen Ryeznik","submitted_at":"2025-09-06T20:40:13Z","abstract_excerpt":"We propose Locally Optimal Restricted Designs (LORDs) for phase I/II dose-finding studies that focus on both efficacy and toxicity outcomes. As an illustrative application, we find various LORDs for a 4-parameter continuation-ratio (CR) model defined on a user-specified dose range, where ethical constraints are imposed to prevent patients from receiving excessively toxic or ineffective doses. We study the structure and efficiency of LORDs across several experimental scenarios and assess the sensitivity of the results to changes in the design problem, such as adjusting the dose range or redefin"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2509.05825","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2509.05825/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2509.05825","created_at":"2026-07-05T12:06:24.849579+00:00"},{"alias_kind":"arxiv_version","alias_value":"2509.05825v1","created_at":"2026-07-05T12:06:24.849579+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2509.05825","created_at":"2026-07-05T12:06:24.849579+00:00"},{"alias_kind":"pith_short_12","alias_value":"DU5C6HLDOX5U","created_at":"2026-07-05T12:06:24.849579+00:00"},{"alias_kind":"pith_short_16","alias_value":"DU5C6HLDOX5UFF67","created_at":"2026-07-05T12:06:24.849579+00:00"},{"alias_kind":"pith_short_8","alias_value":"DU5C6HLD","created_at":"2026-07-05T12:06:24.849579+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q","json":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q.json","graph_json":"https://pith.science/api/pith-number/DU5C6HLDOX5UFF6756KRSVEP2Q/graph.json","events_json":"https://pith.science/api/pith-number/DU5C6HLDOX5UFF6756KRSVEP2Q/events.json","paper":"https://pith.science/paper/DU5C6HLD"},"agent_actions":{"view_html":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q","download_json":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q.json","view_paper":"https://pith.science/paper/DU5C6HLD","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2509.05825&json=true","fetch_graph":"https://pith.science/api/pith-number/DU5C6HLDOX5UFF6756KRSVEP2Q/graph.json","fetch_events":"https://pith.science/api/pith-number/DU5C6HLDOX5UFF6756KRSVEP2Q/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q/action/timestamp_anchor","attest_storage":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q/action/storage_attestation","attest_author":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q/action/author_attestation","sign_citation":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q/action/citation_signature","submit_replication":"https://pith.science/pith/DU5C6HLDOX5UFF6756KRSVEP2Q/action/replication_record"}},"created_at":"2026-07-05T12:06:24.849579+00:00","updated_at":"2026-07-05T12:06:24.849579+00:00"}